Overweight, obesity and risk of premenopausal breast cancer according to ethnicity: A systematic review and dose-response meta-analysis

Obesity Reviews

Volumn 14, Issue 8, 2013, Pages 665-678

  Amadou, A ^a   Ferrari, P ^a   Muwonge, R ^a   Moskal, A ^a   Biessy, C ^a   Romieu, I ^a   Hainaut, P ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Breast cancer; Ethnicity; Obesity; Overweight

Indexed keywords

ARTICLE; ASIAN; BODY HEIGHT; BODY MASS; BODY WEIGHT; BREAST CANCER; CAUCASIAN; DISEASE ASSOCIATION; ETHNICITY; HUMAN; META ANALYSIS; OBESITY; PREMENOPAUSE; SYSTEMATIC REVIEW; WAIST HIP RATIO;

BREAST CANCER; ETHNICITY; OBESITY; OVERWEIGHT;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; BREAST NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; OBESITY; OVERWEIGHT; PREMENOPAUSE; RISK ASSESSMENT; RISK FACTORS; WAIST-HIP RATIO;

EID: 84880593417     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/obr.12028     Document Type: Article

References (59)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Sighoko D, Bah E, Haukka J etal. Population-based breast (female) and cervix cancer rates in the Gambia: evidence of ethnicity-related variations. Int J Cancer 2010; 127: 2248-2256.
3. Parkin DM, Ferlay J, Curado MP etal. Fifty years of cancer incidence: CI5 I-IX. Int J Cancer 2010; 127: 2918-2927.
4. Rose DP, Haffner SM, Baillargeon J. Adiposity, the metabolic syndrome, and breast cancer in African-American and white American women. Endocr Rev 2007; 28: 763-777.
5. Nichols HB, Trentham-Dietz A, Love RR etal. Differences in breast cancer risk factors by tumor marker subtypes among premenopausal Vietnamese and Chinese women. Cancer Epidemiol Biomarkers Prev 2005; 14: 41-47.
6. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371: 569-578.
7. Ogden CL, Yanovski SZ, Carroll MD, Flegal KM. The epidemiology of obesity. Gastroenterology 2007; 132: 2087-2102.
8. Wang Y, Beydoun MA. The obesity epidemic in the United States - gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev 2007; 29: 6-28.
9. Rose DP, Vona-Davis L. Influence of obesity on breast cancer receptor status and prognosis. Expert Rev Anticancer Ther 2009; 9: 1091-1101.
10. Manders P, Pijpe A, Hooning MJ etal. Body weight and risk of breast cancer in BRCA1/2 mutation carriers. Breast Cancer Res Treat 2011; 126: 193-202.
11. Palmer JR, Adams-Campbell LL, Boggs DA, Wise LA, Rosenberg L. A prospective study of body size and breast cancer in black women. Cancer Epidemiol Biomarkers Prev 2007; 16: 1795-1802.
12. Suzuki R, Orsini N, Saji S, Key TJ, Wolk A. Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status - a meta-analysis. Int J Cancer 2009; 124: 698-712.
13. van den Brandt PA, Spiegelman D, Yaun SS etal. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 2000; 152: 514-527.
14. Enger SM, Ross RK, Paganini-Hill A, Carpenter CL, Bernstein L. Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies. Cancer Epidemiol Biomarkers Prev 2000; 9: 681-687.
15. Berstad P, Coates RJ, Bernstein L etal. A case-control study of body mass index and breast cancer risk in white and African-American women. Cancer Epidemiol Biomarkers Prev 2010; 19: 1532-1544.
16. Britton JA, Gammon MD, Schoenberg JB etal. Risk of breast cancer classified by joint estrogen receptor and progesterone receptor status among women 20-44 years of age. Am J Epidemiol 2002; 156: 507-516.
17. Harris HR, Willett WC, Terry KL, Michels KB. Body fat distribution and risk of premenopausal breast cancer in the Nurses' Health Study II. J Natl Cancer Inst 2011; 103: 273-278.
18. Harvie M, Hooper L, Howell AH. Central obesity and breast cancer risk: a systematic review. Obes Rev 2003; 4: 157-173.
19. Huang WY, Newman B, Millikan RC, Schell MJ, Hulka BS, Moorman PG. Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol 2000; 151: 703-714.
20. Lahmann PH, Hoffmann K, Allen N etal. Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC). Int J Cancer 2004; 111: 762-771.
21. Ogundiran TO, Huo D, Adenipekun A etal. Case-control study of body size and breast cancer risk in Nigerian women. Am J Epidemiol 2010; 172: 682-690.
22. Chow LW, Lui KL, Chan JC etal. Association between body mass index and risk of formation of breast cancer in Chinese women. Asian J Surg 2005; 28: 179-184.
23. Iwasaki M, Otani T, Inoue M, Sasazuki S, Tsugane S. Body size and risk for breast cancer in relation to estrogen and progesterone receptor status in Japan. Ann Epidemiol 2007; 17: 304-312.
24. Jordan S, Lim L, Vilainerun D etal. Breast cancer in the Thai Cohort Study: an exploratory case-control analysis. Breast 2009; 18: 299-303.
25. Lukanova A, Bjor O, Kaaks R etal. Body mass index and cancer: results from the Northern Sweden Health and Disease Cohort. Int J Cancer 2006; 118: 458-466.
26. McCredie MR, Dite GS, Southey MC, Venter DJ, Giles GG, Hopper JL. Risk factors for breast cancer in young women by oestrogen receptor and progesterone receptor status. Br J Cancer 2003; 89: 1661-1663.
27. Weiderpass E, Braaten T, Magnusson C etal. A prospective study of body size in different periods of life and risk of premenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 2004; 13: 1121-1127.
28. Tian YF, Chu CH, Wu MH etal. Anthropometric measures, plasma adiponectin, and breast cancer risk. Endocr Relat Cancer 2007; 14: 669-677.
29. Hall IJ, Newman B, Millikan RC, Moorman PG. Body size and breast cancer risk in black women and white women: the Carolina Breast Cancer Study. Am J Epidemiol 2000; 151: 754-764.
30. Wu AH, Yu MC, Tseng CC, Pike MC. Body size, hormone therapy and risk of breast cancer in Asian-American women. Int J Cancer 2007; 120: 844-852.
31. Friedenreich CM, Courneya KS, Bryant HE. Case-control study of anthropometric measures and breast cancer risk. Int J Cancer 2002; 99: 445-452.
32. Ma H, Bernstein L, Ross RK, Ursin G. Hormone-related risk factors for breast cancer in women under age 50 years by estrogen and progesterone receptor status: results from a case-control and a case-case comparison. Breast Cancer Res 2006; 8: R39.
33. Shin A, Matthews CE, Shu XO etal. Joint effects of body size, energy intake, and physical activity on breast cancer risk. Breast Cancer Res Treat 2009; 113: 153-161.
34. Shu XO, Jin F, Dai Q etal. Association of body size and fat distribution with risk of breast cancer among Chinese women. Int J Cancer 2001; 94: 449-455.
35. Rush EC, Freitas I, Plank LD. Body size, body composition and fat distribution: comparative analysis of European, Maori, Pacific Island and Asian Indian adults. Br J Nutr 2009; 102: 632-641.
36. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 1998; 52: 377-384.
37. Vandenbroucke JP, von Elm E, Altman DG etal. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology 2007; 18: 805-835.
38. Orsini N, Bellocco R, Greenland S. Generalized least squares for trend estimation of summarized dose-response data. Stata J 2006; 6: 40-57.
39. Lundqvist E, Kaprio J, Verkasalo PK etal. Co-twin control and cohort analyses of body mass index and height in relation to breast, prostate, ovarian, corpus uteri, colon and rectal cancer among Swedish and Finnish twins. Int J Cancer 2007; 121: 810-818.
40. Michels KB, Terry KL, Willett WC. Longitudinal study on the role of body size in premenopausal breast cancer. Arch Intern Med 2006; 166: 2395-2402.
41. Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 2007; 335: 1134.
42. Tehard B, Clavel-Chapelon F. Several anthropometric measurements and breast cancer risk: results of the E3N cohort study. Int J Obes (Lond) 2006; 30: 156-163.
43. Hamling J, Lee P, Weitkunat R, Ambuhl M. Facilitating meta-analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease category. Stat Med 2008; 27: 954-970.
44. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558.
45. Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
46. Stroup DF, Berlin JA, Morton SC etal. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-2012.
47. Wu MH, Chou YC, Yu JC etal. Hormonal and body-size factors in relation to breast cancer risk: a prospective study of 11, 889 women in a low-incidence area. Ann Epidemiol 2006; 16: 223-229.
48. Hirose K, Tajima K, Hamajima N etal. Association of family history and other risk factors with breast cancer risk among Japanese premenopausal and postmenopausal women. Cancer Causes Control 2001; 12: 349-358.
49. Kuriyama S, Tsubono Y, Hozawa A etal. Obesity and risk of cancer in Japan. Int J Cancer 2005; 113: 148-157.
50. Adebamowo CA, Ogundiran TO, Adenipekun AA etal. Obesity and height in urban Nigerian women with breast cancer. Ann Epidemiol 2003; 13: 455-461.
51. Adebamowo CA, Ogundiran TO, Adenipekun AA etal. Waist-hip ratio and breast cancer risk in urbanized Nigerian women. Breast Cancer Res 2003; 5: R18-R24.
52. Pan WH, Yeh WT. How to define obesity? Evidence-based multiple action points for public awareness, screening, and treatment: an extension of Asian-Pacific recommendations. Asia Pac J Clin Nutr 2008; 17: 370-374.
53. Rose DP, Royak-Schaler R. Tumor biology and prognosis in black breast cancer patients: a review. Cancer Detect Prev 2001; 25: 16-31.
54. Curtis C, Shah SP, Chin SF etal. The genomic and transcriptomic architecture of 2, 000 breast tumours reveals novel subgroups. Nature 2012; 486: 346-352.
55. Huo D, Ikpatt F, Khramtsov A etal. Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer. J Clin Oncol 2009; 27: 4515-4521.
56. Olopade OI, Grushko TA, Nanda R, Huo D. Advances in breast cancer: pathways to personalized medicine. Clin Cancer Res 2008; 14: 7988-7999.
57. Rose DP, Vona-Davis L. Interaction between menopausal status and obesity in affecting breast cancer risk. Maturitas 2010; 66: 33-38.
58. Pandey S, Pandey S, Maheshwari A, Bhattacharya S. The impact of female obesity on the outcome of fertility treatment. J Hum Reprod Sci 2010; 3: 62-67.
59. Bruning PF, Bonfrer JM, van Noord PA, Hart AA, de Jong-Bakker M, Nooijen WJ. Insulin resistance and breast-cancer risk. Int J Cancer 1992; 52: 511-516.